Novartis AG
CELL-BASED ASSAY FOR MEASURING DRUG PRODUCT POTENCY

Abstract:

The invention relates to an in vitro quantative cell-based assay that uses a primary mouse cell model system permissive to viral vector infection and a quantitative high content image-based system for determining potency of a transgene-expressing viral vector drug product for lot disposition.